Contact this trialFirst, we need to learn more about you.
Chemotherapy
ELVN-001 for Chronic Myelogenous Leukemia
Recruiting1 awardPhase 1
Toronto, Ontario
This trial is testing a new drug called ELVN-001 for safety and effectiveness in patients with chronic myeloid leukemia who have not had success with other treatments. The drug aims to reduce cancer markers in the blood to better control the disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service